MedTrace Logo

Real-time Imaging of Holmium Radioembolization: a Feasibility Study

NCT04269499 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2021-06-29

No results posted yet for this study

Summary

This is a feasibility study in which patients with liver tumors are treated with holmium radioembolization under real time MR imaging.

Conditions

Interventions

DEVICE

QuiremSpheres®

Radioembolization with QuiremSpheres® under MR imaging

Sponsors & Collaborators

  • Quirem Medical B.V.

    collaborator INDUSTRY

  • Radboud University Medical Center

    lead OTHER

Principal Investigators

  • Frank Nijsen, PhD · Associate professor

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-11-11
Primary Completion
2021-05-10
Completion
2021-05-10

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04269499 on ClinicalTrials.gov